Publikasi

Decoding Public T-cell Signatures of Disease with Tens ...

In the ever-evolving field of immunology, the study of T-cell responses to vario...

PACE panel urges incentives for exciting new GTT drugs

Luke Rosen had hoped a new treatment would slow the progression of his daughter’...

Ahead of BIO IP Conference, research highlights why bio...

Venture capital funding for life sciences startups plummeted after legal changes...

PACE: Downstream effects of IRA on patients

Three years after the passage of the Inflation Reduction Act (IRA), patient advo...

BIO on the American Road: Indiana, a production powerho...

At a time when the biopharma industry is seeking to increase U.S. manufacturing,...

BIO Coffee Chat: Guiding patients through Part D open e...

Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and run...

Oncologist warns PBM step therapy has ‘crossed a danger...

Cancer patients are suffering serious health consequences because step therapy p...

National Family Caregivers Month: Recognizing 63 millio...

November is National Family Caregivers Month, and to mark the occasion, Bio.News...

Job titles of the future: AI embryologist

Embryologists are the scientists behind the scenes of in vitro fertilization who...

New noninvasive endometriosis tests are on the rise

Shantana Hazel often thought her insides might fall out during menstruation. It ...

Cloning isn’t just for celebrity pets like Tom Brady’s dog

This week, we heard that Tom Brady had his dog cloned. The former quarterback re...

Here’s the latest company planning for gene-edited babies

A West Coast biotech entrepreneur says he’s secured $30 million to form a public...

Here’s why we don’t have a cold vaccine. Yet.

For those of us in the Northern Hemisphere, it’s the season of the sniffles. As ...

How conspiracy theories infiltrated the doctor’s office

As anyone who has googled their symptoms and convinced themselves that they’ve g...

An AI app to measure pain is here

How are you feeling? I’m genuinely interested in the well-being of all my treasu...

GEN Editors Reflect on Six of the Biggest Stories of th...

For the scientific enterprise, 2025 was marked by setbacks and challenges. But s...